|
Dear Friends
Support for AllTrials around the world is growing and we need to keep it that way as we reach some crucial debates. The European Medicines Agency’s proposed policy on publishing and sharing information from clinical trials is open for comment until 30th September. Many of you have been involved in getting your organisations to sign up in support of AllTrials for all trials registered and all results reported. The EMA’s proposals will help to make that happen. But organisations that want to slow or restrict transparency are already making their views known. Please send comments to the EMA before the deadline. Even if you can only comment briefly, please do. It is vital that they hear from the range of bodies and individuals who want an end to hidden trials. We will publish our response next week and share it with you in case that helps. Last month we published the AllTrials manifesto, which sets out challenges that regulators, companies, researchers, professional bodies, journals and others are addressing (or should be) to make sure that all trials are registered and results reported. There have already been meetings, discussions and documents enlarging on some of the points in there, such as how registries can work together to cross reference registered trials and what journals, funders and ethics committees can do to check up on registration. We’re going to link these into the document and map out progress in different parts of the medical research system. Meantime, here is some of the news:
We put campaign news onto our website at www.alltrials.net every day. We are just about to move on making the website, which we put up in a rush at the start, a more rapid and comprehensive way to keep up with the campaign developments across the world. If you have been visiting it and have suggestions please email in the next few days.
Best wishes Síle
|
-
The EMA Proposal:
It gives PHARMA beyond ample protection, but read it if you need proof. -
The reason to write the EMA:
I’ve tried to outline the attempts by PHARMA to undermine the EMA [a deal-breaker?…, an aside…]. -
How to write the EMA:
Their email address is ctdatapolicy@ema.europa.eu, but they suggest that you use a Submission Form [here]. It’s a Word File asking for details and I found it ponderous. Torn with indecision, rather than obsess about which to use, I did both. When you look at the Submission Form, you’ll understand the confusion.
-
How to sign Dr. Healy’s petition:
It’s easy. Just click here…
Sorry, the comment form is closed at this time.